Geisinger hosts Narcan distribution events

SCRANTON/WILKES-BARRE, Pa. – Geisinger’s pharmacy, emergency medicine, addiction medicine and Free2BMom teams are collaborating to host two Narcan® (naloxone) distribution events at the end of August in northeastern Pennsylvania. 

The first event will be held from 11 a.m. to 1 p.m. Wednesday, Aug. 28, at the Schimelfenig Pavilion in Nay Aug Park, located at 500 Arthur Ave. in Scranton. 
The second event will be held from 11 a.m. to 1 p.m. Thursday, Aug. 29, in the parking lot of the Thomas C. Thomas building, located at 90 E. Union St. in Wilkes-Barre. 

At both events, attendees can receive two free boxes of Narcan while supplies last, and healthcare professionals will demonstrate how to properly administer the lifesaving medication. Fentanyl and xylazine testing strips will also be available for those who are interested.

Community health partners at the event can provide information and resources for anyone who is in recovery or seeking recovery. 

About Geisinger

Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across central and northeastern Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the nonprofit system generates more than $8 billion in annual revenues across 163 care sites — including 10 hospital campuses — and Geisinger Health Plan, with more than half a million members in commercial and government plans. Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and is conducting more than 1,400 clinical research studies. With more than 27,000 employees, including 1,800 employed physicians and 5,200 registered nurses, Geisinger is among Pennsylvania’s largest employers, having an estimated economic impact of $16.8 billion on the state’s economy. In 2024, Geisinger joined Risant Health, a nonprofit charitable organization created to expand and accelerate value-based care across the country. Learn more at geisinger.org or follow on Facebook, Instagram and LinkedIn.